HomeACHL • NASDAQ
add
Achilles Therapeutics PLC
Previous close
$1.07
Day range
$1.02 - $1.08
Year range
$0.63 - $1.76
Market cap
43.14M USD
Avg Volume
118.58K
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.80M | -1.62% |
Net income | -16.38M | 2.77% |
Net profit margin | — | — |
Earnings per share | -0.41 | 2.38% |
EBITDA | -16.62M | 1.29% |
Effective tax rate | -0.05% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 95.11M | -33.82% |
Total assets | 131.19M | -33.71% |
Total liabilities | 15.71M | -34.71% |
Total equity | 115.48M | — |
Shares outstanding | 41.09M | — |
Price to book | 0.38 | — |
Return on assets | -32.14% | — |
Return on capital | -34.97% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -16.38M | 2.77% |
Cash from operations | -17.31M | 0.58% |
Cash from investing | -36.00K | 93.30% |
Cash from financing | 0.00 | — |
Net change in cash | -17.19M | -16.56% |
Free cash flow | -12.21M | 6.34% |
About
Founded
2016
Website
Employees
210
